CareDx
CDNA
189 hedge funds and large institutions have $1.73B invested in CareDx in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 53 increasing their positions, 61 reducing their positions, and 12 closing their positions.
392% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 12
78% more capital invested
Capital invested by funds: $971M → $1.73B (+$760M)
75% more call options, than puts
Call options by funds: $5.46M | Put options by funds: $3.13M
31% more funds holding
Funds holding: 144 → 189 (+45)
2.03% less ownership
Funds ownership: 103.75% → 101.72% (-2%)
13% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 61
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.3M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$13.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$10.4M |
Top Sellers
| 1 |
Neuberger Berman Group
New York
|
-$12.2M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$12.2M |
| 3 |
State Street
Boston,
Massachusetts
|
-$12.1M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$8.16M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$7.97M |
CDNA Hedge Fund Activity: Q2 2020 in Review
189 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q2 2020, worth a combined $1.73B — up 78% from $971M a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new CDNA positions and 12 closed out — a net gain of 47 holders — while 53 added to existing stakes and 61 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $48.3M. The largest seller was Neuberger Berman Group, cutting an estimated $12.2M.
- 189 institutional investors held CareDx (CDNA) as of Q2 2020, up from 144 in Q1 2020.
- Funds reported $1.73B of CareDx stock for Q2 2020, up 78% quarter-over-quarter.
- 59 funds opened new CareDx positions in Q2 2020 and 12 closed out, a net change of +47 holders.
- The largest CareDx buyer in Q2 2020 was T. Rowe Price Associates, an estimated $48.3M added.
- The largest CareDx seller in Q2 2020 was Neuberger Berman Group, an estimated $12.2M sold.
Based on aggregated 13F filings for Q2 2020.